Entity Details

Primary name TNNC1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP63316
EntryNameTNNC1_HUMAN
FullNameTroponin C, slow skeletal and cardiac muscles
TaxID9606
Evidenceevidence at protein level
Length161
SequenceStatuscomplete
DateCreated1987-08-13
DateModified2021-06-02

Ontological Relatives

GenesTNNC1

GO terms

Show/Hide Table
GOName
GO:0002086 diaphragm contraction
GO:0003009 skeletal muscle contraction
GO:0005509 calcium ion binding
GO:0005829 cytosol
GO:0005861 troponin complex
GO:0006937 regulation of muscle contraction
GO:0010038 response to metal ion
GO:0014883 transition between fast and slow fiber
GO:0030049 muscle filament sliding
GO:0031013 troponin I binding
GO:0031014 troponin T binding
GO:0032972 regulation of muscle filament sliding speed
GO:0042803 protein homodimerization activity
GO:0043462 regulation of ATPase activity
GO:0048306 calcium-dependent protein binding
GO:0051015 actin filament binding
GO:0055010 ventricular cardiac muscle tissue morphogenesis
GO:0060048 cardiac muscle contraction
GO:1990584 cardiac Troponin complex

Subcellular Location

Show/Hide Table

Domains

Show/Hide Table
DomainNameCategoryType
IPR002048 EF-hand domainDomainDomain
IPR011992 EF-hand domain pairFamilyHomologous superfamily
IPR018247 EF-Hand 1, calcium-binding siteSiteBinding site

Diseases

Show/Hide Table
Disease IDSourceNameDescription
613243 OMIMCardiomyopathy, familial hypertrophic 13 (CMH13)A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. The disease is caused by variants affecting the gene represented in this entry.
611879 OMIMCardiomyopathy, dilated 1Z (CMD1Z)A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00831 TrifluoperazineDrugbanksmall molecule
DB00922 LevosimendanDrugbanksmall molecule
DB01023 FelodipineDrugbanksmall molecule
DB01244 BepridilDrugbanksmall molecule
DB01373 CalciumDrugbanksmall molecule
DB01375 Aluminium monostearateDrugbanksmall molecule
DB03944 5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-OneDrugbanksmall molecule
DB04513 N-(6-Aminohexyl)-5-Chloro-1-NaphthalenesulfonamideDrugbanksmall molecule